These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11311083)

  • 1. Safety of bolus vs infusion thrombolytic therapy.
    Graumlich JF
    JAMA; 2001 Apr; 285(16):2075. PubMed ID: 11311083
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurologic assessment after fibrinolytic therapy for myocardial infarction.
    Mahanes D
    Crit Care Nurse; 2013 Apr; 33(2):78-80. PubMed ID: 23547129
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis.
    Mehta SR; Eikelboom JW; Yusuf S
    Lancet; 2000 Aug; 356(9228):449-54. PubMed ID: 10981887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety outcomes in meta-analyses of phase 2 vs phase 3 randomized trials: Intracranial hemorrhage in trials of bolus thrombolytic therapy.
    Eikelboom JW; Mehta SR; Pogue J; Yusuf S
    JAMA; 2001 Jan 24-31; 285(4):444-50. PubMed ID: 11242429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of microcatheter injections in acute stroke treatment.
    Gupta R
    Nat Rev Neurol; 2009 Apr; 5(4):181-2. PubMed ID: 19347019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project.
    Brass LM; Lichtman JH; Wang Y; Gurwitz JH; Radford MJ; Krumholz HM
    Stroke; 2000 Aug; 31(8):1802-11. PubMed ID: 10926938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial haemorrhage with bolus thrombolytic agents.
    Collen D; Sobel B
    Lancet; 2000 Nov; 356(9244):1848; author reply 1850. PubMed ID: 11117932
    [No Abstract]   [Full Text] [Related]  

  • 8. Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage.
    Giugliano RP; McCabe CH; Antman EM; Cannon CP; Van de Werf F; Wilcox RG; Braunwald E;
    Am Heart J; 2001 May; 141(5):742-50. PubMed ID: 11320361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis medication errors: benefits of bolus thrombolytic agents.
    Cannon CP
    Am J Cardiol; 2000 Apr; 85(8A):17C-22C. PubMed ID: 10793176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracranial haemorrhage with bolus thrombolytic agents.
    Armstrong PW; Granger C; Van de Werf F
    Lancet; 2000 Nov; 356(9244):1849; author reply 1850. PubMed ID: 11117934
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimal thrombolytic strategies for acute myocardial infarction--bolus administration.
    McMechan SR; Adgey AA
    QJM; 1998 Nov; 91(11):719-25. PubMed ID: 10024933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracranial haemorrhage with bolus thrombolytic agents.
    Menown IB; Adgey AA
    Lancet; 2000 Nov; 356(9244):1848-9; author reply 1850. PubMed ID: 11117931
    [No Abstract]   [Full Text] [Related]  

  • 13. Intracranial haemorrhage with bolus thrombolytic agents.
    Andreotti F
    Lancet; 2000 Nov; 356(9244):1849-50. PubMed ID: 11117933
    [No Abstract]   [Full Text] [Related]  

  • 14. Intracranial haemorrhage 4 days after receiving thrombolytic therapy in a young woman with myocardial infarction.
    Ali SM; Rajani AR; Baslaib FO
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23704457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous thrombolytic therapy in myocardial infarction (review)].
    Staroverov II
    Ter Arkh; 2003; 75(10):80-3. PubMed ID: 14669614
    [No Abstract]   [Full Text] [Related]  

  • 16. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.
    Cannon CP; Gibson CM; McCabe CH; Adgey AA; Schweiger MJ; Sequeira RF; Grollier G; Giugliano RP; Frey M; Mueller HS; Steingart RM; Weaver WD; Van de Werf F; Braunwald E
    Circulation; 1998 Dec 22-29; 98(25):2805-14. PubMed ID: 9860780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemorrhagic stroke after thrombolysis with streptokinase.
    Arzu J; Muqueet MA; Sweety SA; Iqbal AM; Kabir FI; Mahmood M
    Mymensingh Med J; 2014 Oct; 23(4):818-20. PubMed ID: 25481610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalamic disequilibrium syndrome after thrombolytic therapy for acute myocardial infarction.
    Nandhagopal R; Vengamma B; Krishnamoorthy SG; Rajasekhar D; Subramanyam G
    Neurology; 2005 Aug; 65(3):494. PubMed ID: 16087930
    [No Abstract]   [Full Text] [Related]  

  • 19. [Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator].
    García-Jiménez A; Iriarte Sotés P; Fernández González CJ; Garrote Freire A; González Tutor J
    An Med Interna; 2003 Mar; 20(3):163-4. PubMed ID: 12756909
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bilateral intracranial hemorrhage following thrombolytic therapy with alteplase (rTPA) in acute myocardial infarction].
    Arbol Linde F; Marcos Sánchez F; Merlo González V; Simón Martín A; Quintana Díaz M; López Onega P
    An Med Interna; 2002 Nov; 19(11):605-6. PubMed ID: 12522906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.